Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation

Abstract Background Microglial activation is a prominent feature of neuroinflammation, which is present in almost all neurodegenerative diseases. While an initial inflammatory response mediated by microglia is considered to be protective, excessive pro-inflammatory response of microglia contributes...

Full description

Bibliographic Details
Main Authors: Xiaoxia Ye, Mingming Zhu, Xiaohang Che, Huiyang Wang, Xing-Jie Liang, Chunfu Wu, Xue Xue, Jingyu Yang
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-019-1644-8
id doaj-98093dfa6b5542489b65ff3be5f0119d
record_format Article
spelling doaj-98093dfa6b5542489b65ff3be5f0119d2021-01-10T12:24:09ZengBMCJournal of Neuroinflammation1742-20942020-01-0117111710.1186/s12974-019-1644-8Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formationXiaoxia Ye0Mingming Zhu1Xiaohang Che2Huiyang Wang3Xing-Jie Liang4Chunfu Wu5Xue Xue6Jingyu Yang7Department of Pharmacology, Shenyang Pharmaceutical UniversityDepartment of Pharmacology, Shenyang Pharmaceutical UniversityDepartment of Pharmacology, Shenyang Pharmaceutical UniversityDepartment of Pharmacology, Shenyang Pharmaceutical UniversityCAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of ChinaDepartment of Pharmacology, Shenyang Pharmaceutical UniversityState Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai UniversityDepartment of Pharmacology, Shenyang Pharmaceutical UniversityAbstract Background Microglial activation is a prominent feature of neuroinflammation, which is present in almost all neurodegenerative diseases. While an initial inflammatory response mediated by microglia is considered to be protective, excessive pro-inflammatory response of microglia contributes to the pathogenesis of neurodegeneration. Although autophagy is involved in the suppression of inflammation, its role and mechanism in microglia are unclear. Methods In the present study, we studied the mechanism by which lipopolysaccharide (LPS) affects microglial autophagy and the effects of autophagy on the production of pro-inflammatory factors in microglial cells by western blotting, immunocytochemistry, transfection, transmission electron microscopy (TEM), and real-time PCR. In a mouse model of neuroinflammation, generated by intraventricular injection of LPS (5 μg/animal), we induced autophagy by rapamycin injection and investigated the effects of enhanced autophagy on microglial activation by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry. Results We found that autophagic flux was suppressed in LPS-stimulated N9 microglial cells, as evidenced by decreased expression of the autophagy marker LC3-II (lipidated form of MAP1LC3), as well as increased levels of the autophagy adaptor protein SQSTM1. LPS significantly decreased Vps34 expression in N9 microglial cells by activating the PI3KI/AKT/MTOR pathway without affecting the levels of lysosome-associated proteins and enzymes. More importantly, overexpression of Vps34 significantly enhanced the autophagic flux and decreased the accumulation of SQSTM1 in LPS-stimulated N9 microglial cells. Moreover, our results revealed that an LPS-induced reduction in the level of Vps34 prevented the maturation of omegasomes to phagophores. Furthermore, LPS-induced neuroinflammation was significantly ameliorated by treatment with the autophagy inducer rapamycin both in vitro and in vivo. Conclusions These data reveal that LPS-induced neuroinflammation in N9 microglial cells is associated with the inhibition of autophagic flux through the activation of the PI3KI/AKT/MTOR pathway, while enhanced microglial autophagy downregulates LPS-induced neuroinflammation. Thus, this study suggests that promoting the early stages of autophagy might be a potential therapeutic approach for neuroinflammation-associated diseases.https://doi.org/10.1186/s12974-019-1644-8LipopolysaccharideMicrogliaAutophagyMTORVps34Neuroinflammation
collection DOAJ
language English
format Article
sources DOAJ
author Xiaoxia Ye
Mingming Zhu
Xiaohang Che
Huiyang Wang
Xing-Jie Liang
Chunfu Wu
Xue Xue
Jingyu Yang
spellingShingle Xiaoxia Ye
Mingming Zhu
Xiaohang Che
Huiyang Wang
Xing-Jie Liang
Chunfu Wu
Xue Xue
Jingyu Yang
Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
Journal of Neuroinflammation
Lipopolysaccharide
Microglia
Autophagy
MTOR
Vps34
Neuroinflammation
author_facet Xiaoxia Ye
Mingming Zhu
Xiaohang Che
Huiyang Wang
Xing-Jie Liang
Chunfu Wu
Xue Xue
Jingyu Yang
author_sort Xiaoxia Ye
title Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
title_short Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
title_full Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
title_fullStr Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
title_full_unstemmed Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
title_sort lipopolysaccharide induces neuroinflammation in microglia by activating the mtor pathway and downregulating vps34 to inhibit autophagosome formation
publisher BMC
series Journal of Neuroinflammation
issn 1742-2094
publishDate 2020-01-01
description Abstract Background Microglial activation is a prominent feature of neuroinflammation, which is present in almost all neurodegenerative diseases. While an initial inflammatory response mediated by microglia is considered to be protective, excessive pro-inflammatory response of microglia contributes to the pathogenesis of neurodegeneration. Although autophagy is involved in the suppression of inflammation, its role and mechanism in microglia are unclear. Methods In the present study, we studied the mechanism by which lipopolysaccharide (LPS) affects microglial autophagy and the effects of autophagy on the production of pro-inflammatory factors in microglial cells by western blotting, immunocytochemistry, transfection, transmission electron microscopy (TEM), and real-time PCR. In a mouse model of neuroinflammation, generated by intraventricular injection of LPS (5 μg/animal), we induced autophagy by rapamycin injection and investigated the effects of enhanced autophagy on microglial activation by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry. Results We found that autophagic flux was suppressed in LPS-stimulated N9 microglial cells, as evidenced by decreased expression of the autophagy marker LC3-II (lipidated form of MAP1LC3), as well as increased levels of the autophagy adaptor protein SQSTM1. LPS significantly decreased Vps34 expression in N9 microglial cells by activating the PI3KI/AKT/MTOR pathway without affecting the levels of lysosome-associated proteins and enzymes. More importantly, overexpression of Vps34 significantly enhanced the autophagic flux and decreased the accumulation of SQSTM1 in LPS-stimulated N9 microglial cells. Moreover, our results revealed that an LPS-induced reduction in the level of Vps34 prevented the maturation of omegasomes to phagophores. Furthermore, LPS-induced neuroinflammation was significantly ameliorated by treatment with the autophagy inducer rapamycin both in vitro and in vivo. Conclusions These data reveal that LPS-induced neuroinflammation in N9 microglial cells is associated with the inhibition of autophagic flux through the activation of the PI3KI/AKT/MTOR pathway, while enhanced microglial autophagy downregulates LPS-induced neuroinflammation. Thus, this study suggests that promoting the early stages of autophagy might be a potential therapeutic approach for neuroinflammation-associated diseases.
topic Lipopolysaccharide
Microglia
Autophagy
MTOR
Vps34
Neuroinflammation
url https://doi.org/10.1186/s12974-019-1644-8
work_keys_str_mv AT xiaoxiaye lipopolysaccharideinducesneuroinflammationinmicrogliabyactivatingthemtorpathwayanddownregulatingvps34toinhibitautophagosomeformation
AT mingmingzhu lipopolysaccharideinducesneuroinflammationinmicrogliabyactivatingthemtorpathwayanddownregulatingvps34toinhibitautophagosomeformation
AT xiaohangche lipopolysaccharideinducesneuroinflammationinmicrogliabyactivatingthemtorpathwayanddownregulatingvps34toinhibitautophagosomeformation
AT huiyangwang lipopolysaccharideinducesneuroinflammationinmicrogliabyactivatingthemtorpathwayanddownregulatingvps34toinhibitautophagosomeformation
AT xingjieliang lipopolysaccharideinducesneuroinflammationinmicrogliabyactivatingthemtorpathwayanddownregulatingvps34toinhibitautophagosomeformation
AT chunfuwu lipopolysaccharideinducesneuroinflammationinmicrogliabyactivatingthemtorpathwayanddownregulatingvps34toinhibitautophagosomeformation
AT xuexue lipopolysaccharideinducesneuroinflammationinmicrogliabyactivatingthemtorpathwayanddownregulatingvps34toinhibitautophagosomeformation
AT jingyuyang lipopolysaccharideinducesneuroinflammationinmicrogliabyactivatingthemtorpathwayanddownregulatingvps34toinhibitautophagosomeformation
_version_ 1724343020776587264